| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 09/12/2007 | EP1465481A4 Knockout swine and methods for making the same |
| 09/12/2007 | EP1463836A4 Vector mediated organelle transfection |
| 09/12/2007 | EP1407013B1 Mutations in ion channels |
| 09/12/2007 | EP1354945B1 Method of identifying within a rodent a dna encoding physiologically active polypeptide |
| 09/12/2007 | EP1320542B9 Group b streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof |
| 09/12/2007 | EP1307564B1 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 09/12/2007 | EP1303617B1 Mutant muscle-specific enhancers |
| 09/12/2007 | EP1299541B1 Method for producing and using novel human defensins as biologically active proteins for treating infections and other illnesses |
| 09/12/2007 | EP0844004B1 Collagen containing gene preparations |
| 09/12/2007 | EP0776161B2 Use of a viral vector encoding a cytochrome p450 gene in combination with a chemotherapeutic agent for selectively destroying neoplastic cells |
| 09/12/2007 | EP0651807B1 New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents |
| 09/12/2007 | CN101035906A Telomelysin-GFP gene-containing recombinant virus |
| 09/12/2007 | CN101035901A Addition of transgenes into adenoviral vectors |
| 09/12/2007 | CN101035835A Biodegradable cationic polymers |
| 09/12/2007 | CN101032623A Targeting chitosan carrier guided by folic acid receptor and the preparing method and the application |
| 09/12/2007 | CN100336823C Specific chicken CpG ODN and its application |
| 09/12/2007 | CN100336567C Medical cornea paster and its preparation method |
| 09/11/2007 | US7268227 Posh nucleic acids, polypeptides and related methods |
| 09/11/2007 | US7268222 For use in therapeutic, diagnostic, and pharmacogenomic applications |
| 09/11/2007 | US7268214 peptidomimetics; enhanced uptake via gastrointestinal systems |
| 09/11/2007 | US7268208 Solubility in aqueous solvents; for use in diagnosis, therapy |
| 09/11/2007 | US7268207 Nucleotide sequences coding polypeptide for use in the treatment of cancer |
| 09/11/2007 | US7268121 Suppression of nuclear factor-κB dependent processes using oligonucleotides |
| 09/11/2007 | US7268120 Administering into a muscle of a mammal with cancer or metastasis thereof, a DNA plasmid comprising a polynucleotide which encodes interferon-alpha or an active fragment thereof, operably associated with a promoter |
| 09/11/2007 | US7267978 Improve the specificity and safety of gene delivery vectors, and improve the prostate-specificity and activity of genetic constructs targeted for prostate-specific expression |
| 09/11/2007 | US7267977 Peripheral-type benzodiazepine receptor: a tool for detection, diagnosis, prognosis, and treatment of cancer |
| 09/11/2007 | US7267963 Modified plant viruses and methods of use thereof |
| 09/11/2007 | US7267824 Veterinary medicine; induce immunology response |
| 09/11/2007 | US7267819 Composition comprising and method of using angiopoietin-like protein 3 Angptl3 |
| 09/11/2007 | US7267815 Methods and reagents for the enhancement of virus transduction in the bladder epithelium |
| 09/11/2007 | CA2204357C Novel adenoviral vectors, packaging cell lines, recombinant adenoviruses and methods |
| 09/11/2007 | CA2172963C Aspartoacylase gene, protein, and methods of screening for mutations associated with canavan disease |
| 09/07/2007 | WO2007100576A2 Compositions and methods for repressing the ink4a and arf senescence pathways |
| 09/07/2007 | WO2007100568A2 T cell receptors and related materials and methods of use |
| 09/07/2007 | WO2007100091A1 Composition for suppressing the expression of fucosyltransferase |
| 09/07/2007 | WO2007100058A1 Rheumatoid arthritis test method and treating method |
| 09/07/2007 | WO2007099981A1 Galactose derivative, drug carrier and medicinal composition |
| 09/07/2007 | WO2007099921A1 PEPTIDE BINGING TO PILRα, POLYNUCLEOTIDE ENCODING THE SAME AND APPLICATION THEREOF |
| 09/07/2007 | WO2007099869A1 Therapeutic and preventive agent for hcv |
| 09/07/2007 | WO2007099661A1 Polymer micelle complex including nucleic acid |
| 09/07/2007 | WO2007099660A1 Polymer micelle complex including nucleic acid |
| 09/07/2007 | WO2007099650A1 Peptide lipid-containing carrier and method for introducing compound into cells using same |
| 09/07/2007 | WO2007098950A1 Master gene of arteriogenesis |
| 09/07/2007 | WO2007098607A1 Methods and compositions to treat and detect misfolded-sod1 mediated diseases |
| 09/07/2007 | WO2007098588A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 09/07/2007 | WO2007058991A3 Mutations and polymorphisms of c-abl |
| 09/07/2007 | WO2006079217A8 Treatment of degenerative diseases with the x-linked inhibitor of apoptosis |
| 09/07/2007 | CA2644552A1 Peptide lipid-containing carrier and method for introducing compound into cells using same |
| 09/07/2007 | CA2644426A1 Extracellular matrix/metastasis modifer genes for the prevention or inhibition of metastasis or growth of tumor and for characterization of tumor |
| 09/07/2007 | CA2644377A1 Master gene of arteriogenesis |
| 09/07/2007 | CA2643260A1 Method and process for preparing cardiolipin |
| 09/07/2007 | CA2643100A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 09/07/2007 | CA2642848A1 Methods and compositions to treat and detect misfolded-sod1 mediated diseases |
| 09/07/2007 | CA2638797A1 Galactose derivative, drug carrier and medicinal composition |
| 09/07/2007 | CA2638757A1 Chimeric adenoviral vectors |
| 09/07/2007 | CA2623413A1 Stem cell factor-like protein scfa1 and uses thereof |
| 09/06/2007 | US20070209083 Cell and transgenic animal modelling human antigenic presentation and their uses |
| 09/06/2007 | US20070209082 Txr1 and enhanced taxane sensitivity based on the modulation of a pathway mediated thereby |
| 09/06/2007 | US20070208167 Compounds and methods for modulating activation of NF-kappaB |
| 09/06/2007 | US20070208043 Gene expression inhibition; p38 map kinase inhibitors |
| 09/06/2007 | US20070207975 Materials and methods for treating and preventing Her-2/neu overexpressing, FAS-elevated cancer cells |
| 09/06/2007 | US20070207974 Short interference RNA duplexes, when introduced into mammalian cells in culture, perform sequence-specific inhibition of target mRNA without inducing an interferon response; specific gene silencing |
| 09/06/2007 | US20070207966 mixing a small interfering RNA with a conjugate comprising a cholesterol residue covalently bonded to oligoarginine through a formate residue linker, thereby forming the complex; carrier for delivery of an siRNA targeted to vascular endothelial growth factor for the treatment for cancer |
| 09/06/2007 | US20070207546 Bovine immunodeficiency virus (biv) based vectors |
| 09/06/2007 | US20070207523 Mammalian t-type calcium channels |
| 09/06/2007 | US20070207462 Preventive/Remedy for Respiratory Diseases |
| 09/06/2007 | US20070207194 Gene or drug delivery system |
| 09/06/2007 | US20070207184 Implantable medical device coated with a bioactive agent |
| 09/06/2007 | US20070207166 Method of Using Adenoviral Vectors to Induce an Immune Response |
| 09/06/2007 | US20070207164 Methods of using flt3-ligand in the treatment of cancer |
| 09/06/2007 | US20070207163 Recombinant soluble Fc receptors |
| 09/06/2007 | US20070207149 Cancer treatment using viruses and camptothecins |
| 09/06/2007 | US20070207148 Genes associated with obesity and methods for using the same |
| 09/06/2007 | US20070207143 Anti-cd26 monoclonal antibodies as therapy for diseases associated with cells expressing cd26 |
| 09/06/2007 | US20070207140 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same |
| 09/06/2007 | US20070207124 Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury pain |
| 09/06/2007 | US20070207123 Amelioration of effects of cigarette smoke |
| 09/06/2007 | US20070207120 Selective Killing Of Cancer Cells By Induction Of Acetyltransferase Via Tnf-Alpha And Il-6 |
| 09/05/2007 | EP1829972A2 DNA sequences having anti-repressor activity |
| 09/05/2007 | EP1829971A1 DNA sequences having anti-repressor activity |
| 09/05/2007 | EP1829967A1 Method of diagnosing malignant lymphoma and estimating the prognosis thereof |
| 09/05/2007 | EP1829963A1 Novel shuttle vector |
| 09/05/2007 | EP1829892A2 Staphylococcus aureus proteins and nucleic acids |
| 09/05/2007 | EP1829555A2 Method of enhancing delivery of a therapeutic nucleic acid |
| 09/05/2007 | EP1829551A1 Modified heat shock protein-antigenic peptide complex |
| 09/05/2007 | EP1829547A2 Treatment of neurodegenerative disease through intracranial delivery of short interfering RNA (siRNA) |
| 09/05/2007 | EP1828415A1 Method of inhibiting expression of target mrna using sirna consisting of nucleotide sequence complementary to said target mrna |
| 09/05/2007 | EP1828390A2 Chimeric vectors |
| 09/05/2007 | EP1828245A2 Igf-1 isoforms |
| 09/05/2007 | EP1828219A1 Sirna silencing of apolipoprotein b |
| 09/05/2007 | EP1827504A2 Recombinant bcg strains with enhanced ability to escape the endosome |
| 09/05/2007 | EP1827503A1 Rnai inhibition of ctgf for treatment of ocular disorders |
| 09/05/2007 | EP1827502A2 Methods for targeted delivery of genetic material to the liver |
| 09/05/2007 | EP1827474A2 Heat shock proteins (hsp) and supraventricular arrhythmia |
| 09/05/2007 | EP1827101A2 Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases |
| 09/05/2007 | EP1730286A4 Therapeutic anti-cancer dna |
| 09/05/2007 | EP1667763B1 Delivering genetic material to a stimulation site |
| 09/05/2007 | EP1539802B1 Novel kcnq polypeptides and their uses in the diagnosis of mental disorders |
| 09/05/2007 | EP1485475B1 Hybrid and single chain meganucleases and use thereof |
| 09/05/2007 | EP1267917B1 Angiogenic onchocerca volvulus proteins and uses thereof |